Boudreau Philip P's Form 4 filing
Abbott Laboratories (ABT) · filed Apr 27, 2026
- Accession no.
- 0001805099-26-000006
- Filed
- Apr 27, 2026
- Trade date
- Apr 23, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $201.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Boudreau Philip PCIK 0001805099 | Officer (EVP AND CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | Common shares without par value | ILess common codeAcquired | +8,909 | $92.04 | +$819,984.36 | 9,276 | Indirect | |
| Apr 23, 2026 | Common shares without par value | PPurchaseAcquired | +2,200 | $91.50 | +$201,300 | 2,200 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.